NICCOLI ASABELLA, ARTOR
 Distribuzione geografica
Continente #
NA - Nord America 13.849
AS - Asia 6.223
EU - Europa 5.007
SA - Sud America 1.502
AF - Africa 180
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 26.784
Nazione #
US - Stati Uniti d'America 13.671
SG - Singapore 2.781
CN - Cina 1.610
BR - Brasile 1.345
DE - Germania 1.025
HK - Hong Kong 929
SE - Svezia 860
UA - Ucraina 745
RU - Federazione Russa 679
IT - Italia 529
FI - Finlandia 412
VN - Vietnam 380
GB - Regno Unito 310
FR - Francia 126
IN - India 124
CA - Canada 92
BD - Bangladesh 67
MX - Messico 61
AR - Argentina 60
CI - Costa d'Avorio 60
BE - Belgio 51
NL - Olanda 46
IE - Irlanda 45
TR - Turchia 44
IQ - Iraq 42
PL - Polonia 35
CZ - Repubblica Ceca 31
EC - Ecuador 29
ID - Indonesia 29
ZA - Sudafrica 29
IR - Iran 28
EG - Egitto 27
ES - Italia 22
SA - Arabia Saudita 22
JP - Giappone 20
PK - Pakistan 20
VE - Venezuela 20
AT - Austria 19
MA - Marocco 18
UZ - Uzbekistan 18
LT - Lituania 16
IL - Israele 14
CO - Colombia 13
AU - Australia 12
JO - Giordania 12
KE - Kenya 12
AE - Emirati Arabi Uniti 10
CL - Cile 9
DZ - Algeria 9
HU - Ungheria 9
KR - Corea 8
RO - Romania 8
UY - Uruguay 8
PE - Perù 7
PY - Paraguay 7
RS - Serbia 7
AZ - Azerbaigian 6
EU - Europa 6
TH - Thailandia 6
CR - Costa Rica 5
DK - Danimarca 5
ET - Etiopia 5
KW - Kuwait 5
LB - Libano 5
NP - Nepal 5
SN - Senegal 5
AL - Albania 4
AO - Angola 4
BH - Bahrain 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
KG - Kirghizistan 4
MK - Macedonia 4
PS - Palestinian Territory 4
TN - Tunisia 4
TW - Taiwan 4
BG - Bulgaria 3
BO - Bolivia 3
EE - Estonia 3
GE - Georgia 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
PH - Filippine 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CG - Congo 2
LK - Sri Lanka 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BW - Botswana 1
Totale 26.770
Città #
Jacksonville 1.740
Chandler 1.441
Singapore 1.383
Woodbridge 1.309
Ashburn 924
Hong Kong 921
Houston 746
Fairfield 696
Ann Arbor 689
Nyköping 534
Cambridge 428
Lawrence 371
Beijing 368
Roxbury 365
Nanjing 360
Wilmington 299
New York 268
Seattle 251
Des Moines 248
Boardman 217
Dallas 210
Los Angeles 178
Princeton 142
Dong Ket 135
Dearborn 131
São Paulo 131
Bari 111
Brooklyn 106
Inglewood 103
Ho Chi Minh City 102
Hebei 88
Santa Clara 87
Buffalo 83
Nanchang 83
Munich 75
Shenyang 75
Jiaxing 73
Abidjan 60
Hanoi 59
Tianjin 57
Helsinki 55
Brussels 49
Moscow 49
Changsha 44
Dublin 44
Paris 42
San Diego 40
Council Bluffs 37
Frankfurt am Main 34
Rio de Janeiro 34
Belo Horizonte 33
London 33
Ostuni 32
San Francisco 32
Curitiba 31
Washington 31
Brasília 30
Montreal 30
Brno 29
Guangzhou 29
Warsaw 29
Boston 26
Pune 26
Chicago 25
Norwalk 25
The Dalles 24
Hefei 22
Stockholm 22
Campinas 21
Chennai 21
Columbus 21
Jakarta 20
Modugno 20
Porto Alegre 20
Toronto 20
Mexico City 19
Jinan 18
Johannesburg 18
Phoenix 18
Shanghai 18
Tashkent 18
Tokyo 18
Trani 18
Kunming 17
Poplar 17
Turku 17
Baghdad 16
Kafr ash Shaykh 15
Amsterdam 14
Atlanta 14
Rome 14
Salvador 14
San Mateo 14
Manchester 13
Milan 13
Orem 13
Riyadh 13
Zhengzhou 13
Amman 12
Auburn Hills 12
Totale 17.113
Nome #
F-18 FDG PET/CT in the diagnosis of a rare case of neurosarcoidosis in a patient with diabetes insipidus 197
Pediatric Hodgkin Lymphoma: Predictive value of interim 18F-FDG PET/CT in therapy response assessment 187
DRD2 genotype-based variation of default mode network activity and of its relationship with striatal DAT binding 186
A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: The first southern Italy experience 184
A rare case of osteopetrosis mimicking osteosarcoma: 18F-FDG PET/CT findings in an unexpected diagnosis 179
Diagnostic Performance of 18F-FDG PET/CT Semiquantitative Analysis in the Management of Sarcoidosis 179
Comparison of 18F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. 169
Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance 165
99mTc-diphosphonates bone scintigraphy for vitality evaluation in cleft palate 161
Impact of pre-treatment variables on the completion of 223radium-dichloride therapy in mCRPC patients with bone metastases 159
Can SPET/CT Technique Improve the Sentinel Lymph Node Radio- Guided Research in Cutaneous Malignant Melanoma? 158
Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings 152
18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography 150
Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study 150
Long-Term Functional Assessment of Antegrade Colonic Enema for Combined Incontinence and Constipation Using a Modified Marsh and Kiff Technique. 146
123I-FP-CIT SPET study in a rare case of midbrain tremor associated to HSV-1 brainstem encephalitis 141
Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques 141
18F-FDG PET/CT in therapy response and in predicting responders or non-responders in malignant pleural mesothelioma patients, by using semi-quantitative mRECIST and EORTC criteria 140
124Iodine: A Longer-Life Positron Emitter Isotope—New Opportunities in Molecular Imaging 139
18F-FDG PET/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up) 138
How often suspected pulmonary embolism is diagnosed and its main diagnostic characteristics, in an emergency nuclear medicine service? Four years experience 137
18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnosis and Post-Therapeutic Treatment in a Patient with an Early Stage of Retroperitoneal Fibrosis 136
"[111In-DTPA]-octreotide scintigraphy in the evaluation of patients with NET: comparison with CgA assay and CT imaging 136
Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives 136
Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation 135
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease 133
Subject rehabilitation in secondary dysphagia due to neurodegenerative diseases: a prospective and observation study of twenty patients with fiberoptic endoscopic evaluation of swallowing (fees) and oral-pharyngo-esophageal scintigraphy (OPES) 133
(123I)FP-CIT SPET study to evaluate Primary Blepharospasm 131
123I FP-CIT SPET study in a rare case of midbrain tremor associated to HSV-1 brainstem encephalitis 130
Comparison between CT Net enhancement and PET/CT SUV for N staging of gastric cancer: A case series 129
18F-FDGPET/CT: diabetes and hyperglycaemia 128
Increased and normalized uptake of 18F-FDG in a case of bone periprosthetic infection treated by antibiotics 128
99mTc- DTPA mixed warm water colonic scintigraphy to evaluate antegrade colonic enema in patients undergone marsh & kift technique for fecal incontinence and costipation 127
18F-FDG PET/CT in staging and restaging cholangiocarcinoma [La PET/TC con 18F-FDG nella stadiazione, diagnosi e ristadiazione del colangiocarcinoma] 126
Role of 18FDG-PET/CT semiquantitative parameters in the evaluation of therapy response in patients affected by recurrent pleural mesothelioma 125
(123I)FP-CIT SPET study to evaluate Primary Blepharospasm 124
Role of WB-MR/DWIBS compared to 18F-FDG PET/CT in the therapy response assessment of lymphoma 124
Comparison of the Diagnostic Value of MRI and Whole Body 18F-FDG PET/CT in Diagnosis of Spondylodiscitis 123
Brain F-18 Fluorocholine PET/CT for the Assessment of Optic Pathway Glioma in Neurofibromatosis-1 122
Acute pulmonary embolism: comparison and integration of perfusion lung scintigraphy with multislice spiral CT 121
Lymph node staging in early prostatic carcinoma with radioguided sentinel node biopsy 121
Pediatric Hodgkin Lymphoma: visual and semiquantitative analysis of interim 18FDG-PET/CT in predicting treatment response and outcome 120
A retrospective study comparing contrast-enhanced computed tomography with 18F-FDG-PET/CT in the early follow-up of patients with retroperitoneal sarcomas 119
Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease 118
18F-FDG PET/CT Metabolic activity assessment in infective and neoplastic diseases: A patient with systemic hydatidosis and concomitant Burkitt lymphoma 117
Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125. 115
18F-FDG PET/CT usefulness vs Tc99m-Tetrofosmin in the assessment of malignant brain gliomas: Report of two cases 113
18-Fluorine-labelled 2-deoxy-2-fluoro-D-glucose PET/CT in staging and restaging of primary sarcoidosis 112
18-Fluorine-labelled 2-deoxy-2-fluoro-D-glucose Positron emission Tomography in staging and restaging of primary sarcoidosis 112
123I FP-CIT SPET study to detect striatum dopamine transporter level in primary blepharospasm 112
Role of (18)F-FDG PET/CT in the evaluation of response to antibiotic therapy in patients affected by infectious spondylodiscitis 112
18F-FDG PET/CT in a patient with clinical suspicion of giant cell arteritis [La gestione di un caso di arterite a cellule giganti con la 18F-FDG PET/TC] 111
Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study. 111
A simple method for correcting overestimated glomerular filtration rate in obese subject evaluated by the Cockcroft and Gault formula: a comparison with 51Cr EDTA clearance 108
Tyrosine-Kinase inhibitors therapies with mainly anti-angiogenic activity in advanced renal cell carcinoma: Value of PET/CT in response evaluation 107
Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging 107
Whole body MR-DWIBS vs 18F-FDG-PET/CT in the study of malignant tumors: a retrospective study 106
18F-FDG PET/CT: bone marrow uptake and bone marrow biopsy in initial staging of non Hodgkin’s lymphoma patients”; . 104
18FDG-PET/CT qualitative analysis for evaluation of neoadjuvant chemoradiotherapy in low rectal cancer; can be it useful by itself? Assessment by Mandard’s Tumor Regression and (y)pTNM staging 104
Radio-Guided Sentinel Lymph Node Identification by Lymphoscintigraphy Fused with an Anatomical Vector Profile: Clinical Applications 102
null 102
18F-FDG PET/CT evaluation in diagnosis and follow up of patients with hepato-cellular carcinoma 100
18-Fluorini-labelled 2-deoxy-2-fluoro-D-glucose Positron Emission Thomography computed tomography in restaging and follow-up of primary sarcoidosis 100
[111In-DTPA]-octreotide whole body and SPECT scintigraphy in the evaluation of patients with NET: comparison with CgA assay and CT imaging 100
The impact of lung perfusion scintigraphy in the emergency management of patients with suspected pulmonary embolism. 98
Useful diagnostic biometabolic data obtained by PET/CT and MR fusion imaging using open source software 97
18F-FDG PET/CT evaluation in diagnosis and follow-up of patients with hepato-cellular carcinoma 96
18F-FDG positron emission tomography/computed tomography and 99mTc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease 96
Usefulness of 18F-FDG PET/CT in patients with Cardiac Implantable Electronic Device Suspected for Late Infection 94
123I-FP-CIT SPET study to detect striatum dopamine transporter level in primari blepharospasm 93
18-Fluorine-labelled 2-deoxy-2-fluoro-D-glucose Positron Emission Thomography 7 computed tomography in restaging and follow-up of primary sarcoidosis 93
Myocardial sympathetic innervation perfusion in patients underwent laser percutaneous transmyocardial revascularization 92
Nuclear Medicine Methods in Scrotal Imaging 92
A comparison of the Parametes in Quantitative US Technique and Dual Energy X-Ray Absorbiomentry in Post-Menopausal Women: Preliminary Results 92
Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis 92
[123I]FP-CIT SPECT imaging of SERT in the mesenchefal in patients with PD, PSP AND LBD 91
Scintigraphy evaluation of antegrade colonic enema in patients undegone Marsh & Kiff technique operation for fecal incontinence and costipation 91
18F-FDG PET/CT in ocular and orbital abnormalities not only neopastic: Comparison with traditional imaging [La 18F-FDG PET/CT nello studio delle lesioni orbitarie e oculari neoplastiche e non: comparazione con l'imaging tradizionale] 91
Unusual 18F-FDG PET/CT finding of an oxyphil parathyroid adenoma in a patient with Hodgkin's Lymphoma 91
Early evaluation of immunotherapy response in lymphoma patients by 18f-fdg pet/ct: A literature overview 91
18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography. 90
Added value of SPECT/CT over planar imaging in improving sentinel node detection in breast cancer patients. Il valore aggiunto della SPECT/CT rispetto all’imaging planare nel migliorare la ricerca del linfonodo sentinella in pazienti con carcinoma mammario 90
18F-FDG PET/CT a confronto con le metodiche standard per il follow-up nella sospetta recidiva di mesotelioma pleurico 89
Functional assessment of antegrade colonic enema for combined incontinence and costipation dy a modified Marsh and Kiff technique 89
Prospective analysis of 18F-FDG PET/CT’ predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotheraphy and conservative surgery. 89
18F-FDG PET/CT contribution to diagnosis and treatment response of rhino-orbital-cerebral mucormycosis 88
null 88
The new lens dose limit: implication for occupational radiation protection 88
Role of 18F-FDG PET/CT in the evaluation of response to antibiotic therapy in patients affected by infectious spondilodiscitis 87
Unusual sentinel lymph nodes detected by lymphoscintigraphy in cutaneous melanoma patients [Linfonodi sentinella "inusuali" alla linfoscintigrafia in pazienti con melanoma cutaneo] 86
A phase II study employing Hepatic Intraarterial Irinotecan Drug-Eluiting Beads (DEBIRI) as salvage therapy in liver metastatic colorectal cancer patient: the first South Italy experience 85
Scintigraphy evaluation of antegrade colonic enema in patients undegone Marsh & Kiff technique operation for fecal incontinence and costipation 84
Sickle cell diseases: What can nuclear medicine offer? 84
“[111In-DTPA]-octreotide scintigraphy in the evaluation of patients with NET: comparison with CgA assay and CT imaging” 83
Atypical appearance of pneumatosis intestinalis at multidetector CT [Aspetto atipico della pneumatosi intestinale in TC multidetettore] 81
Correlation among Global Skeletal Uptake by 99mTc-MDP Bone Scintigraphy and Markers of bone Metabolism (Neoformation and Riabsorption) in Patients with Advanced Prostate Cancer 80
Correlation between 18F-FDG PET/CT and histological status of carotid artery plaques: preliminary results 79
Perfusion scintigraphy and ECG-gated study to evaluate the effects of the implant of autologous mononuclear bone marrow stromal stem cell (ssc) in infarcted myocardium in pigs: preliminary results 79
Radioguided sentinel lymph node biopsy in oral cancer cavity and oropharynx squamous-cell carcinoma 79
[111In-DTPA]-octreotide whole body and SPECT scintigraphy in the evaluation of patients with NET: comparison with CgA assay and CT imaging 79
Totale 11.625
Categoria #
all - tutte 122.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.559 0 0 0 0 0 123 281 103 323 382 137 210
2021/20222.310 78 315 16 132 141 92 77 122 108 90 391 748
2022/20233.716 604 311 167 381 524 431 61 383 664 33 74 83
2023/20241.339 121 277 67 65 131 329 24 84 9 59 17 156
2024/20255.133 110 76 553 173 150 398 317 472 220 271 720 1.673
2025/20264.874 1.572 372 582 1.016 1.183 149 0 0 0 0 0 0
Totale 27.244